These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35228335)

  • 1. Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke.
    Mendelson SJ; Zhang S; Matsouaka R; Xian Y; Shah S; Lytle BL; Solomon N; Schwamm LH; Smith EE; Saver JL; Fonarow G; Holl J; Prabhakaran S
    Neurology; 2022 Apr; 98(16):e1596-e1604. PubMed ID: 35228335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.
    Boehme AK; Siegler JE; Mullen MT; Albright KC; Lyerly MJ; Monlezun DJ; Jones EM; Tanner R; Gonzales NR; Beasley TM; Grotta JC; Savitz SI; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e255-61. PubMed ID: 24468069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in refusal of stroke thrombolysis in Chicago.
    Mendelson SJ; Aggarwal NT; Richards C; O'Neill K; Holl JL; Prabhakaran S
    Neurology; 2018 Jan; 90(5):e359-e364. PubMed ID: 29298854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.
    Messé SR; Khatri P; Reeves MJ; Smith EE; Saver JL; Bhatt DL; Grau-Sepulveda MV; Cox M; Peterson ED; Fonarow GC; Schwamm LH
    Neurology; 2016 Oct; 87(15):1565-1574. PubMed ID: 27629092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke.
    Song S; Liang L; Fonarow GC; Smith EE; Bhatt DL; Matsouaka RA; Xian Y; Schwamm LH; Saver JL
    JAMA Neurol; 2019 Apr; 76(4):430-439. PubMed ID: 30667466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke.
    Masrur S; Cox M; Bhatt DL; Smith EE; Ellrodt G; Fonarow GC; Schwamm L
    J Am Heart Assoc; 2015 Sep; 4(10):e002193. PubMed ID: 26408015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study.
    Hsia AW; Edwards DF; Morgenstern LB; Wing JJ; Brown NC; Coles R; Loftin S; Wein A; Koslosky SS; Fatima S; Sánchez BN; Fokar A; Gibbons MC; Shara N; Jayam-Trouth A; Kidwell CS
    Stroke; 2011 Aug; 42(8):2217-21. PubMed ID: 21719765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China.
    Wang HY; Gu HQ; Zhou Q; Jiang YY; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Li H; Liu C; Li ZX; Wang YJ; Jiang Y
    BMJ Open; 2022 Jun; 12(6):e055055. PubMed ID: 35750455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
    Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
    Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.
    Johnston SC; Fung LH; Gillum LA; Smith WS; Brass LM; Lichtman JH; Brown AN
    Stroke; 2001 May; 32(5):1061-8. PubMed ID: 11340210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.
    Dodds JA; Xian Y; Sheng S; Fonarow GC; Bhatt DL; Matsouaka R; Schwamm LH; Peterson ED; Smith EE
    Neurology; 2019 Jun; 92(24):e2784-e2792. PubMed ID: 31092622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Ischemic Stroke Interventions in the United States and Racial, Socioeconomic, and Geographic Disparities.
    de Havenon A; Sheth K; Johnston KC; Delic A; Stulberg E; Majersik J; Anadani M; Yaghi S; Tirschwell D; Ney J
    Neurology; 2021 Dec; 97(23):e2292-e2303. PubMed ID: 34649872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging temporal trends in tissue plasminogen activator use: Results from the BASIC project.
    Domino JS; Baek J; Meurer WJ; Garcia N; Morgenstern LB; Campbell M; Lisabeth LD
    Neurology; 2016 Nov; 87(21):2184-2191. PubMed ID: 27770075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.
    Aparicio HJ; Carr BG; Kasner SE; Kallan MJ; Albright KC; Kleindorfer DO; Mullen MT
    J Am Heart Assoc; 2015 Oct; 4(10):e001877. PubMed ID: 26467999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.
    Qian F; Fonarow GC; Smith EE; Xian Y; Pan W; Hannan EL; Shaw BA; Glance LG; Peterson ED; Eapen ZJ; Hernandez AF; Schwamm LH; Bhatt DL
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):284-92. PubMed ID: 23680966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.